Company / SG&A per Share
Voyager Therapeutics, Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.65
FY2025
5-year range
$0.65 / $0.97
FY2021-FY2025
Trend
-7.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $0.22 in FY2016 to $0.97 in FY2021.
Based on SEC 10-K filings.
0.65 in FY2025 with a 5-year CAGR of -6.5%.
Improved from $0.96 to $0.65 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -10.8%
- 5-Year CAGR
- -6.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 7.0% year-over-year.
- Peak sg&a per share was recorded in FY2021.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 0.34 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.65 | -7.0% |
| FY2024 | $0.70 | -27.1% |
| FY2023 | $0.96 | +4.5% |
| FY2022 | $0.92 | -5.1% |
| FY2021 | $0.97 | +6.0% |
| FY2020 | $0.92 | +50.4% |
| FY2019 | $0.61 | +45.1% |
| FY2018 | $0.42 | +8.6% |
| FY2017 | $0.39 | +76.5% |
| FY2016 | $0.22 | -87.7% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026